Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization

被引:43
作者
Baker, VL
Rone, HM
Pasta, DJ
Nelson, HP
Gvakharia, M
Adamson, GD
机构
[1] Fertil Physicians No Calif, San Jose, CA USA
[2] Reprod Hlth No Calif, San Jose, CA USA
[3] DMA Corp, Palo Alto, CA USA
关键词
birth weight; gestational age; in vitro fertilization; spontaneous abortion; thyroid stimulating hormone (TSH);
D O I
10.1016/j.ajog.2006.03.040
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of this study was to determine if pregnancy outcome for women undergoing in vitro fertilization is correlated with pre-conception, thyroid-stimulating hormone level. Study design: We performed a retrospective cohort study of in vitro fertilization cycles in our private practice with an initial positive serum human chorionic gonadotropin level and thyroid-stimulating hormone level available (n = 364). We examined whether or not birth outcome differed between cycles in which the thyroid-stimulating hormone was > 2.5 mIU/L compared with cycles with a thyroid-stimulating hormone level of <= 2.5 mIU/L. Logistic regression was used to determine the association between thyroid-stimulating hormone level and spontaneous abortion rate. Results: Delivery outcome was available for 195 cycles, 36% of which had a thyroid-stimulating hormone level > 2.5. The gestational age at delivery was higher in cycles with a thyroid-stimulating hormone <= 2.5 than for cycles with a thyroid-stimulating hormone > 2.5 (38.5 vs 38.0 weeks for singletons, 36.0 vs 34.6 weeks for twins, overall P = .012 for thyroid-stimulating hormone level). The mean birth weight for cycles with a thyroid-stimulating hormone <= 2.5 was higher than for cycles with a thyroid-stimulating hormone > 2.5 (7.33 vs 6.78 lbs for singletons, P = .024 and 5.36 vs 4.83 lbs for twins, P = .023). Restricting analysis to cycles where the woman was not taking thyroid replacement did not change the overall conclusions. There was a trend toward increasing risk of miscarriage with increasing thyroid-stimulating hormone level in nondonor cycles, controlling for age and day 3 follicle-stimulating hormone level. but this trend did not reach statistical significance. Conclusion: A pre-conception thyroid-stimulating hormone level > 2.5 mIU/L is associated with a lower gestational age at delivery and lower birth weight in women undergoing in vitro fertilization. (c) 2006 Mosby, Inc. All rights reserved.
引用
收藏
页码:1668 / 1674
页数:7
相关论文
共 21 条
  • [1] Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism
    Alexander, EK
    Marqusee, E
    Lawrence, J
    Jarolim, P
    Fischer, GA
    Larsen, PR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (03) : 241 - 249
  • [2] Maternal thyroid deficiency and pregnancy complications: implications for population screening
    Allan, WC
    Haddow, JE
    Palomaki, GE
    Williams, JR
    Mitchell, ML
    Hermos, RJ
    Faix, JD
    Klein, RZ
    [J]. JOURNAL OF MEDICAL SCREENING, 2000, 7 (03) : 127 - 130
  • [3] American College of Obstetricians and Gynecologists, 2002, OBSTET GYNECOL, V100, P387, DOI DOI 10.1016/S0029-7844(02)02196-8
  • [4] Narrow individual variations in serum T4 and T3 in normal subjects:: A clue to the understanding of subclinical thyroid disease
    Andersen, S
    Pedersen, KM
    Bruun, NH
    Laurberg, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) : 1068 - 1072
  • [5] Fetal loss associated with excess thyroid hormone exposure
    Anselmo, J
    Cao, DC
    Karrison, T
    Weiss, RE
    Refetoff, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (06): : 691 - 695
  • [6] Subclinical hypothyroidism and pregnancy outcomes
    Casey, BM
    Dashe, JS
    Wells, CE
    McIntire, DD
    Byrd, W
    Leveno, KJ
    Cunningham, FG
    [J]. OBSTETRICS AND GYNECOLOGY, 2005, 105 (02) : 239 - 245
  • [7] Serum prolactin and TSH in an in vitro fertilization population: Is there a link between fertilization and thyroid function?
    Cramer, DW
    Sluss, PM
    Powers, RD
    McShane, P
    Ginsburg, ES
    Hornstein, MD
    Vitonis, AF
    Barbieri, RL
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2003, 20 (06) : 210 - 215
  • [8] Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
    Haddow, JE
    Palomaki, GE
    Allan, WC
    Williams, JR
    Knight, GJ
    Gagnon, J
    O'Heir, CE
    Mitchell, ML
    Hermos, RJ
    Waisbren, SE
    Faix, JD
    Klein, RZ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) : 549 - 555
  • [9] Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994):: National Health and Nutrition Examination Survey (NHANES III)
    Hollowell, JG
    Staehling, NW
    Flanders, WD
    Hannon, WH
    Gunter, EW
    Spencer, CA
    Braverman, LE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) : 489 - 499
  • [10] Prospective study of the spontaneous course of subclinical hypothyroidism: Prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies
    Huber, G
    Staub, JJ
    Meier, C
    Mitrache, C
    Guglielmetti, M
    Huber, P
    Braverman, LE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07) : 3221 - 3226